If you’ve read the cost page for almost any other peptide on this site, you know the shape of the answer: there’s no single price, and what you pay depends on which route you take — telehealth, an in-person clinic, or a compounding pharmacy. That framework works because those peptides have a legitimate supply path you can put a number on.
Selank doesn’t. And that’s the most important thing to understand about its cost before any dollar figure: the usual three-column comparison mostly doesn’t apply, because two of the three columns don’t legitimately exist for Selank in the US. This page is about what that actually means for what you’d pay — and why the cheap-looking number you’ll see quoted is misleading in a specific way.
Why Selank doesn’t have a normal US price
A regulated US price for a peptide comes from a regulated US supply chain. For something like BPC-157, that chain runs through a licensed prescriber and a compounding pharmacy that can legally prepare it — which is why you can quote a real monthly figure. Selank isn’t in that situation.
Selank is not an FDA-approved drug in the United States. It’s approved as a finished pharmaceutical in Russia, where it’s been used for generalized anxiety, but that approval has no force here. And unlike the cohort of peptides whose US compounding status is actively being worked through in 2026, Selank cannot currently be legally compounded by a US pharmacy — it isn’t on the authorized bulks list that would let a 503A pharmacy prepare it. The precise regulatory mechanics, and how that differs from compounds with a clearer path, are covered on how to get Selank and are peptides legal in the US.
The cost consequence is simple and stark: there is no pharmacy counter, telehealth program, or clinic dispensary selling you legitimately compounded Selank at a published price. So when you see a “Selank price,” it is almost always the price of a research-grade vial — and that’s a different product than the regulated, lab-tested compound a pharmacy price would buy you.
Note: “Cheap” and “expensive” only mean something when you’re comparing the same thing. The low Selank numbers you’ll see aren’t a cheaper version of pharmacy Selank — there is no pharmacy Selank. They’re the price of an unregulated product that hasn’t been independently verified.
The numbers you’ll actually see (and what they buy)
With the caveat above firmly in place, here is what’s quoted in the US market as of mid-2026, so you can read the figures honestly rather than be surprised by them.
Research-grade vials. The dominant figure. Lyophilized Selank vials from research-chemical suppliers run roughly $30-80, with a common single-vial price landing around $40. Because most people use Selank intranasally, pre-mixed nasal sprays are also widely sold and are often the cheapest format per milligram. On a per-milligram basis Selank is inexpensive — frequently in the single-digit-dollars-per-mg range — far below newer or harder-to-synthesize peptides.
Why it’s structurally cheap. Selank is a short seven-residue peptide built from ordinary amino acids, so it’s straightforward and low-cost to manufacture, and high-volume production keeps the per-milligram price down. The low number is real chemistry, not a discount.
What the vial price does not include. This is the whole point. A research-grade vial is sold “for research use only.” That label isn’t a formality — it means the product isn’t intended or guaranteed as medicine, and identity, purity, and actual concentration vary between sellers and even between batches. The price buys a substance that should be Selank; it does not buy verification that it is, at the strength claimed, free of contaminants. The side-effects page covers why that uncertainty matters for safety.
So the honest read of the headline number is: $30-80 buys you an unverified product, and the gap between that and a real pharmacy price is the cost of regulation, testing, and oversight you’re not getting.
The costs the sticker price hides
If you only look at the vial, you’ll badly underestimate the real cost of using Selank responsibly — and badly overestimate the value of using it cheaply.
Clinical oversight, if you want it done safely. The safer route is to involve a licensed clinician rather than self-source. That adds a consultation — commonly $99-400 depending on the provider and whether it’s telehealth or in-person — plus any baseline evaluation they run. A provider working honestly with Selank is buying you assessment and monitoring, not a cheaper vial. The mechanics of that encounter are on the Selank prescription page.
The verification you can’t buy at this price. With a regulated, lab-tested compound, third-party purity and identity testing is built into what you pay for. With a $40 research vial, it isn’t — and there’s no practical way for an individual to independently confirm what’s in it. That missing verification is a real cost; it’s just paid in risk rather than dollars.
No insurance offset, ever. US insurers don’t cover Selank under any circumstances — it has no FDA-approved indication to bill against. (This is one of the few places where GLP-1 weight-loss drugs differ sharply: insurance sometimes touches those, but never a non-approved nootropic peptide.) So whatever you spend on Selank is fully out of pocket, with no path to reimbursement.
The format multiplier. Because nasal sprays and lyophilized vials are priced differently and used differently, two people “on Selank” can have very different monthly spends. There’s no standard package, which makes any single monthly figure unreliable.
How Selank’s cost picture compares to other peptides
Putting Selank next to its neighbors makes the oddity clear.
Against a compoundable peptide like BPC-157, Selank looks cheaper — but that comparison is unfair, because the BPC-157 price buys a pharmacy-prepared, prescription product and the Selank price buys a research vial. You’re comparing a regulated route to an unregulated one.
Against GLP-1 weight-loss drugs, Selank looks dramatically cheaper — branded GLP-1s can run well over a thousand dollars a month at list price — but those are FDA-approved medicines with clinical-trial backing, manufacturing oversight, and (sometimes) insurance coverage. Again, different category, different thing.
Its closest true peer is Semax, the other Russian-developed nootropic peptide, which sits in a similar pricing world for similar reasons. The parallels and the small differences are covered on Semax cost. The shared lesson: both are cheap on paper precisely because they sit outside the regulated supply chain, not in spite of it.
What “value” actually means for Selank
The instinct with a $40 vial is to treat the low price as the headline feature. For Selank that instinct is exactly backwards. The price is low because the product is unregulated; the regulation is the thing that would make the price worth paying.
If you’re weighing Selank on cost, the useful question isn’t “how cheap can I get it?” It’s “what am I actually buying at this price, and what would it cost to do this with verification and oversight?” A clinician-led path costs more up front — a consult, an evaluation, ongoing monitoring — but what you’re paying for is the thing the cheap vial leaves out: some assurance that the product is what it claims to be, and someone watching for problems. Whether that’s worth it depends on you, but it should be a conscious trade, not a default to the lowest sticker.
For whether Selank is worth pursuing at all — separate from cost — the benefits page grades the actual evidence, and Selank for anxiety covers its most-studied use. This page only answers the money question.
The honest bottom line
Selank’s US “cost” can’t be quoted the way a compoundable peptide’s can, because there’s no legitimate priced supply channel for it here. The numbers you’ll see — roughly $30-80 a vial, less per milligram, often cheaper still as a nasal spray — are research-grade prices for an unregulated product whose contents aren’t guaranteed. That low figure isn’t a bargain version of pharmacy Selank; it’s the price of skipping the regulation, testing, and oversight entirely. If you add the clinical care that makes Selank use defensible, the real cost is higher and harder to pin down — and that higher number is buying the part of the picture the cheap vial leaves out.
This cost summary is current as of June 20, 2026. US peptide pricing and regulatory status are moving quickly in 2026 and may change.
Frequently asked questions
How much does Selank cost in the US?
There is no regulated US price. Selank isn't FDA-approved and can't be legally compounded by a US pharmacy, so the telehealth-and-pharmacy pricing that applies to peptides like BPC-157 doesn't exist for it. The only widely quoted figures are research-grade vials at roughly $30-80, which are sold 'for research use only' and aren't medicine you can verify.
Why is Selank so much cheaper than GLP-1 peptides?
Two reasons. Selank is a short seven-amino-acid peptide that's simple and cheap to synthesize, and decades of Russian pharmaceutical manufacturing have driven the per-milligram cost down. But the bigger reason the headline number looks low is that you're comparing an unregulated research vial to a regulated, prescribed, lab-tested product — different things at different price points for a reason.
Will insurance cover Selank?
No. US insurers don't cover Selank under any circumstances because it isn't an FDA-approved drug and has no approved indication here. Insurance occasionally touches GLP-1 weight-loss drugs, but never a non-approved nootropic peptide like Selank.
Is the low price a good deal?
Not in the way it looks. A $40 vial only seems cheap if the contents match the label — and with gray-market research peptides, identity, purity, and concentration vary and aren't guaranteed. A low price on an unverified product isn't a saving; it's a different and larger risk.
What's the real all-in cost of using Selank?
More than the vial. If you involve a clinician (the safer path), add a consult — often $99-400 — plus any baseline evaluation. If you self-source, the 'cost' includes the unmeasurable risk of an unverified injectable or spray with no oversight. The sticker price is the smallest part of the picture.